Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Pyxis Oncology (PYXS) Accumulated Depreciation & Amortization (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 33.9% to $7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Dec 2025, up 33.9% year-over-year, with the annual reading at $7.0 million for FY2025, 33.9% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $7.0 million at Pyxis Oncology, up from $5.2 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $7.0 million in Q4 2025, with the low at $5.2 million in Q4 2024.